Network pharmacology and molecular docking results showed Reduning may regulate ERBB2 phosphorylation and the MAPK signaling pathway through stigmasterol, quercetin, and beta-sitosterol, thereby preventing sepsis-induced pulmonary fibrosis. Here, ERBB2 is linked to pulmonary fibrosis.